Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid

FI Roullet, L Wollaston, D Decatanzaro, JA Foster - Neuroscience, 2010 - Elsevier
FI Roullet, L Wollaston, D Decatanzaro, JA Foster
Neuroscience, 2010Elsevier
Experiments in rodents have indicated that maternal valproic acid (VPA) exposure has
permanent adverse effects upon neurological and behavioral development. In humans,
prenatal exposure to VPA can induce fetal valproate syndrome, which has been associated
with autism. The present study examined mouse pups exposed in utero to VPA, measuring
physical development, olfactory discrimination, and social behavior as well as expression of
plasticity-related genes, brain derived neurotrophic factor (BDNF) and NMDA receptor …
Experiments in rodents have indicated that maternal valproic acid (VPA) exposure has permanent adverse effects upon neurological and behavioral development. In humans, prenatal exposure to VPA can induce fetal valproate syndrome, which has been associated with autism. The present study examined mouse pups exposed in utero to VPA, measuring physical development, olfactory discrimination, and social behavior as well as expression of plasticity-related genes, brain derived neurotrophic factor (BDNF) and NMDA receptor subunits NR2A and NR2B. VPA-exposed mice showed delayed physical development, impaired olfactory discrimination, and dysfunctional pre-weaning social behavior. In situ hybridization experiments revealed lower cortical expression of BDNF mRNA in VPA animals. These results support the validity of the VPA mouse model for human autism and suggest that alterations in plasticity-related genes may contribute to the behavioral phenotype.
Elsevier